BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Isarna Therapeutics

Isarna Therapeutics logo

Founded
1998
Geography
Germany based
Funding
$113.116 M

Isarna Therapeutics has an unmatched commitment to developing TGF-B inhibitors that stimulate the human immune system to effectively fight cancer. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.

Technologies

Antisense Oligonucleotides  


Posts Mentioning This Company

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet